WELLINGTON MANAGEMENT GROUP LLP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$83,856,051
-21.4%
2,651,994
+1.4%
0.02%
-15.0%
Q2 2023$106,654,544
-3.5%
2,615,364
-11.8%
0.02%
-9.1%
Q1 2023$110,548,038
+58.9%
2,966,140
+48.7%
0.02%
+57.1%
Q4 2022$69,577,221
+116.1%
1,994,188
+246.6%
0.01%
+100.0%
Q3 2022$32,193,000
-5.7%
575,292
-12.8%
0.01%0.0%
Q2 2022$34,156,000
-39.6%
659,899
-15.2%
0.01%
-30.0%
Q1 2022$56,575,000
-21.7%
778,512
+27.5%
0.01%
-16.7%
Q4 2021$72,215,000
-7.8%
610,748
+4.6%
0.01%
-7.7%
Q3 2021$78,317,000
+53.2%
583,808
+85.0%
0.01%
+44.4%
Q2 2021$51,106,000315,6410.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders